DCC Healthcare

DCC Healthcare is a broadly based international healthcare products and services group with operations encompassing:

  • sales and marketing of healthcare products and provision of related services to the hospital sector in Ireland and Britain;
  • provision of outsourced solutions to health and beauty industry in Europe;
  • sales and marketing of mobility and rehabilitation products in Britain, Ireland, Australia, New Zealand and other markets.

DCC Healthcare currently employs 1,350 people.

Businesses and Markets

Hospital Supplies & Services

Fannin is the market leader in healthcare products and related services to hospitals in Ireland. Products include intravenous pharmaceuticals, medical, surgical and laboratory products. The business markets and sells a broad range of leading brands – including Cardinal, Grifols, Molnlycke, Oxoid and Synthes. DCC now has strong growth platform in the provision of value added distribution services to British hospitals and healthcare owners.  Fannin also has a specialist sales and marketing business in Britain focused on intravenous pharmaceuticals and surgical devices.

Health & Beauty Solutions

DCC is a leading provider of "source to shelf" outsourced solutions to the health and beauty industry, principally in the areas of nutraceuticals (vitamin and health supplements), skin care and hair care. DCC provides a wide range of product formats (tablets, soft gel capsules, creams and liquids), packing and other services from its three MHRA licensed facilities in Britain.

DCC Mobility and Rehab

DCC  is involved in the design, development procurement, sales and marketing of mobility and rehabilitation products, with operations in Britain, Ireland, Australia and New Zealand. DCC is the market leader in the physiotherapy product supplies sector in Britain, Australia and New Zealand, with a broad product portfolio principally marketed under its own Days Healthcare, Physio-Med and Metron brands. Products are developed and designed in-house with manufacturing outsourced, mainly to Asian and eastern European partners. DCC has its own Asian procurement and quality control team based in Shenzhen, China.

Strategy and Development

DCC Healthcare's strategy is to build a substantial international healthcare products and services business, focused on the sales and marketing of healthcare products and the provision of value added services to the healthcare industry, including the health & beauty sector.

DCC has an active acquisition programme focused on opportunities to accelerate the growth and development of its existing businesses including expanding their geographic reach.   

Performance Management

DCC Healthcare's business is constantly monitored through a broad range of performance indicators, principally focused on sales growth, margin management, operational and cost efficiencies, cash flow and return on capital employed. Over the past ten years DCC Healthcare has achieved a compound annual growth rate of 6.8% in operating profit .

Relevant Links
http://www.ausmedic.com
http://www.dayshealthcare.com
http://www.dcchealthandbeauty.com
http://www.fannin.ie
http://www.physio-med.com